Balyasny Asset Management is a global multi-strategy asset management firm and registered investment adviser investing across public markets and selective private-company financings. It has acted as a lead or co-lead investor in venture rounds, including early- and later-stage companies across biotechnology, pharmaceuticals, oncology, defense technology, AI-enabled services, PropTech, real estate, education and media, with activity across the United States, Europe and the UK.